SQ31844 is a renin inhibitor belonging to the imidazolyl alcohol class, used for its potent in vitro inhibition of primate renin and in vivo suppression of plasma renin activity (PRA); it demonstrates dose-dependent PRA inhibition in conscious, sodium-depleted cynomolgus monkeys following intravenous administration (0.001–1.0 μmol/kg), with complete inhibition at the highest dose; it also lowers arterial blood pressure when administered intravenously at 10 μmol/kg or via infusion; in sodium-replete monkeys, it inhibits the rise in arterial blood pressure and PRA induced by exogenous monkey renin; upon oral administration at 50 μmol/kg, SQ31844 significantly suppresses PRA (by 80%).